| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |